ag 127 has been researched along with Primary Peritonitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacher, J; Banks, SM; Danner, RL; Eichacker, PQ; Elin, RJ; Freeman, BD; Gazit, A; Hoffman, A; Levitzki, A; Natanson, C; Novogrodsky, A; Quezado, ZM; Sevransky, JE; Shaked, G; Thomas, ML | 1 |
| Caputi, AP; Chatterjee, PK; Cuzzocrea, S; Dugo, L; Fulia, F; Mazzon, E; McDonald, MC; Paola, RD; Thiemermann, C | 1 |
2 other study(ies) available for ag 127 and Primary Peritonitis
| Article | Year |
|---|---|
Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.
Topics: Animals; Benzylidene Compounds; Disease Models, Animal; Dogs; Enzyme Inhibitors; Escherichia coli Infections; gamma-Glutamyltransferase; Heart; In Vitro Techniques; Lung; Multiple Organ Failure; Nitriles; Peritonitis; Phenols; Protein-Tyrosine Kinases; Shock, Septic; Signal Transduction; Tumor Necrosis Factor-alpha; Tyrphostins | 1997 |
The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat.
Topics: Animals; Enzyme Inhibitors; Male; Models, Animal; Multiple Organ Failure; Nitric Oxide; Peritonitis; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Tyrphostins; Zymosan | 2002 |